The North America intracranial aneurysm market was valued at USD 540.41 Million in 2025 and is expected to grow at a CAGR of 7.60%, reaching USD 1124.21 Million by 2035. The market growth is driven by improved diagnostic imaging, greater public awareness, and rising prevalence of hypertension.
Base Year
Historical Period
Forecast Period
Around 6.8 million people have an unruptured intracranial aneurysm in the United States, with the rate of rupture estimated to be 8-10 per every 100,000 individuals annually. This rising prevalence is expected to impact market demand.
The development of new treatment options with higher success rates and better safety profiles is likely to augment the North America intracranial aneurysm market share in coming years. In December 2023, Galaxy Therapeutics’ Endovascular Aneurysm Lattice (SEAL) embolization system, showed a 100% technical success rate, 76.9% rate of progressive complete occlusion, and 0% retreatment rate in the PRE-SEAL IT trial.
In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., gaining access to Cerus Endovascular's Contour Neurovascular System and Neqstent Coil Assisted Flow Diverter, thereby strengthening its existing portfolio of aneurysm treatment solutions. Such strategic partnerships are expected to elevate market value in the region.
Compound Annual Growth Rate
7.6%
Value in USD Million
2026-2035
*this image is indicative*
Intracranial aneurysm, also known as brain aneurysm or cerebral aneurysm is a condition characterized by ballooning or bulging in a blood vessel in the brain. Rupturing or leaking of the aneurysm can cause bleeding in the brain called hemorrhagic stroke. A ruptured aneurysm can be life-threatening and requires immediate treatment. Advancements in endovascular techniques, including improvements in device technology and materials used for endovascular coiling and flow diversion are expected to significantly impact North America intracranial aneurysm market demand. In addition, the rising patient inclination towards minimally invasive procedures owing to the associated benefits such as fewer complications and reduced recovery time are poised to influence the market dynamics.
The market is experiencing a surge in the demand for intracranial aneurysm treatments which can be attributed to the increased prevalence of the condition in North America. Recent data suggests that around 6.8 million people have an unruptured intracranial aneurysm in the United States, with the rate of rupture estimated to be 8-10 per every 100,000 individuals annually. With around 30,000 people suffering from an intracranial aneurysm rupture every year in the region, the market size is likely to expand in the coming years.
The key players in the market are actively investing in developing new treatment options for intracranial aneurysms with higher success rates and better safety profiles, thereby contributing to the North America intracranial aneurysm market growth. In December 2023, data revealed at the Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference demonstrated positive results for a device abelled “the third way” developed by Galaxy Therapeutics (a United States-based, clinical-stage medical device company). It is developed to treat intracranial aneurysms using an intrasaccular approach. The one-year results of a first-in-human study, the PRE-SEAL IT trial which evaluated the efficacy of the novel Saccular Endovascular Aneurysm Lattice (SEAL) embolization system, showed a 100% technical success rate, 76.9% rate of progressive complete occlusion at 1 year and 0% retreatment rate. Thus, the SEAL device exhibited effectiveness as well as a good safety profile across a range of challenging aneurysms. The development of such innovative devices is anticipated to propel the market growth in the forecast period.
One of the significant North America intracranial aneurysm market trends is the increased merger and acquisition initiatives among the leading market players. In May 2023, Stryker Corporation completed the acquisition of Cerus Endovascular Ltd., a United States-based medical technology company specializing in interventional neuroradiology devices for the treatment of intracranial aneurysms. Under this acquisition, the company will get access to Cerus Endovascular's CE Marked products, the Contour Neurovascular System as well as the Neqstent Coil Assisted Flow Diverter, strengthening Stryker’s existing portfolio of aneurysm treatment solutions. Such strategic partnerships are expected to foster better access to intracranial aneurysm treatments and are expected to elevate market value in the region.
The report offers a detailed analysis of the market based on the following segments:
Breakup by Treatment Type
Breakup by End-Use
Breakup by Region
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Upto 15% Off
USD
$2699 $2429
$4299 $3869
$5799 $4949
$6999 $5949
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market is anticipated to grow at a CAGR of 7.60% during the forecast period of 2026-2035, driven by the growing prevalence of intracranial aneurysms in the region.
The rising patient inclination towards minimally invasive procedures and increasing healthcare investments are fuelling the market demand.
One of the significant trends in the market is the increased merger and acquisition initiatives among the leading market players. In May 2023, Stryker Corporation acquired Cerus Endovascular Ltd., strengthening its existing portfolio of aneurysm treatment solutions.
Based on the treatment type, the market is segmented into surgical clipping, endovascular coiling, and flow diverters, among others.
By end user, the market is divided into hospitals, and clinics, among others.
The market segmentation by countries includes the United States of America and Canada.
The key players in the market are Stryker, B. Braun Melsungen AG, MicroPort Scientific Corporation, Medtronic, Johnson & Johnson, Codman Neuro (Integra Lifesciences), Raumedic AG, Delta Surgical, Penumbra, Inc., and Mizuho Medical Co. Ltd.
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by End-Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share